Loading...
•
Sep 30, 2020
Bio-Techne Q1 2021 Earnings Report
Bio-Techne's Q1 2021 financial results were released, showing revenue growth and increased profitability.
Key Takeaways
Bio-Techne reported a strong first quarter for fiscal year 2021, with organic revenue growth of 10% and adjusted EPS increasing by 35%. The company benefited from the reopening of customer sites and demand for its life science tools and diagnostic reagents.
Organic revenue increased by 10% to $204.2 million.
GAAP EPS was $0.83, while adjusted EPS was $1.43, a 35% increase year-over-year.
Diagnostics and Genomics segment delivered 17% organic growth.
Adjusted operating margin increased to 38.2%.
Revenue by Segment
Forward Guidance
The company anticipates a positive long-term outlook for sales growth resulting from expected future funding increases within life-science research in response to the current pandemic.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...